Vi Duong, MD
Urogynecology and Reconstructive Pelvic Surgery · Lake Forest, ILNPI 1346772225
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,515 of the $4,444 with a category attached, or 79.1%. 5 manufacturers reported payments, led by Coloplast at 39.6% of the total. Reporting peaked in 2023 at $1,946 and has fallen 64.4% since, to $692 in 2025.
Across 57 payments — averaging $77.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$2K
- Boston Scientific$1K
- Axonics, Inc.$842
- Medtronic$391
- AbbVie$131
What the payments were for
- Travel & lodging$92921%
- Food & beverage$3,51579%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 19 | $1,762 |
| Boston Scientific | 21 | $1,318 |
| Axonics, Inc. | 10 | $842 |
| Medtronic | 5 | $391 |
| AbbVie | 2 | $131 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$1,070
- Bulkamid$710
- Axonics$566
- Advantage System$155
- Solyx SIS System$129
- GENERAL PAIN MANAGEMENT$123
- UPSYLON$110
How this compares
$4,444 in reported general payments places this provider in the 60th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
See all urogynecology and reconstructive pelvic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 64 | $47,804 |
| GemtesaVibegron | 45 | $34,992 |
| Estradiol | 64 | $5,562 |
| Methenamine Hippurate | 48 | $2,943 |
| Trospium Chloride | 26 | $2,350 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 38 | $332 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Lake Forest
- Abraham ShashouaChicago$339K
- Peter SandSkokie$185K
- Akira GillinghamChicago$58K
- Roger GoldbergSkokie$54K
- Kimberly KentonChicago$43K
- Traci BeckChicago$32K
- Raja ChatterjiSouth Elgin$30K
- Margaret MuellerChicago$26K
- Lisa JohnsonOak Lawn$24K
- Henry ChillEvanston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.